CLOV CLOVER HEALTH INV CORP

Clover Health Medicare Advantage Plans Earn 3.5 Star Rating for 2023

Clover Health Medicare Advantage Plans Earn 3.5 Star Rating for 2023

FRANKLIN, Tenn., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced that for the 2021 measurement year, the Centers for Medicare and Medicaid Services (“CMS”) has rated its PPO Medicare Advantage (“MA”) plan at 3.5 stars and increased the rating of its HMO MA plan from 3 stars to 3.5 stars on the Medicare Star Ratings. Currently, over 90% of Clover’s MA membership is served through its PPO plan.

“Our goal is to provide everyone with access to personalized primary care from a physician that they trust, and maintaining our star rating validates our differentiated approach,” said Jamie Reynoso, Chief Operating Officer of Clover. “Sustaining such a high level of plan quality, especially during a once in a century pandemic, is a testament to the operational excellence we’ve developed as an organization.”

Every year, Medicare evaluates plans based on a 5-star rating system.

The statements contained in this document are solely those of the authors and do not necessarily reflect the views or policies of CMS. The authors assume responsibility for the accuracy and completeness of the information contained in this document.

About Clover Health:

Clover Health (Nasdaq: CLOV) is a physician enablement company focused on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is underpinned by our proprietary software platform, Clover Assistant, which is designed to aggregate patient data from across the health ecosystem to support clinical decision-making and improve health outcomes. We operate two distinct lines of business: Insurance and Non-Insurance. Through our Insurance line of business, we provide PPO and HMO plans to Medicare Advantage members in several states. Our Non-Insurance line of business aims to reduce expenditures and enhance the quality of care for patients enrolled in fee-for-service Medicare. Clover’s corporate headquarters are in Franklin, Tenn.

Visit:

Press Contact:

Andrew Still-Baxter

Emma Baron

 

Investor Relations Contact:

Ryan Schmidt

 



EN
11/10/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CLOVER HEALTH INV CORP

 PRESS RELEASE

Clover Health to Participate in Upcoming J.P. Morgan 2026 Healthcare C...

Clover Health to Participate in Upcoming J.P. Morgan 2026 Healthcare Conference WILMINGTON, Del., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Executive Officer, Andrew Toy, will present at the J.P. Morgan 2026 Healthcare Conference on Thursday, January 15, 2026, at 11:15 a.m. Eastern Time. A live webcast and replay of the presentation and Q&A session will be accessible on Clover Health's investor relations website at . About Clover Health:Clover Health (Nasdaq: CLOV) is a p...

 PRESS RELEASE

Clover Health to Participate in Upcoming 2025 Citi Global Healthcare C...

Clover Health to Participate in Upcoming 2025 Citi Global Healthcare Conference WILMINGTON, Del., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the 2025 Citi Global Healthcare Conference on Thursday, December 4, 2025, at 11:15 a.m. Eastern Time. A live webcast and replay of the presentation will be accessible on Clover Health's investor relations website at . About Clover Health:Clover Health (Nasdaq: CLOV) is a physician en...

 PRESS RELEASE

Clover Health Reports Third Quarter 2025 Results

Clover Health Reports Third Quarter 2025 Results Business Highlights: Generates third quarter year-to-date positive Adjusted EBITDA profitability, on a wide network, while growing membership by 35% and revenue by 39% year-over-year, despite a greater proportion of new members relative to returning member baseHigh coverage of Clover Assistant, including within new cohorts, will result in improved total cost of care Strong retention, above-market growth, and profitable returning member cohorts position Clover for improved positive FY26 Financial Results Financial Results: Third quarter 202...

 PRESS RELEASE

Clover Health Announces Chelsea Clinton to Step Down from Board Follow...

Clover Health Announces Chelsea Clinton to Step Down from Board Following Eight Years of Service WILMINGTON, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced that Chelsea Clinton, the longest-serving member of its Board of Directors, having joined the Board in early 2017, will conclude her service as of October 31, 2025. During her over eight years of dedicated service, Ms. Clinton played a pivotal role in guiding Clover’s evolution from a privately held company serving 30,000 members to a...

 PRESS RELEASE

Primary Care Physician Use of Counterpart Assistant (CA) Technology As...

Primary Care Physician Use of Counterpart Assistant (CA) Technology Associated With Earlier Diagnosis And Less Frequent Hospitalization In Underserved Populations New whitepaper demonstrates how CA enables primary care teams in resource-constrained settings to prevent, detect, and manage chronic disease. SAN FRANCISCO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a leading AI-powered physician-enablement platform, today released a w...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch